|
Market Closed -
Nasdaq
01:30:00 30/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 6.525 USD | +2.92% |
|
+38.24% | -54.02% |
| 04/09 | NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road | CI |
| 12/08 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
| Market Cap | 2.99Cr 2.68Cr 2.47Cr 2.23Cr 4.18Cr 284.42Cr 4.24Cr 29Cr 12Cr 148.85Cr 11Cr 11Cr 471.45Cr | P/E 2026 * |
-1.03x | P/E 2027 * | -1.11x |
|---|---|---|---|---|---|
| Enterprise Value | 2.99Cr 2.68Cr 2.47Cr 2.23Cr 4.18Cr 284.42Cr 4.24Cr 29Cr 12Cr 148.85Cr 11Cr 11Cr 471.45Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
81.41% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NXTC | Delayed | |
CBOE
| NXTC | Real-time |
Last Transcript: NextCure, Inc.
| 1 day | +2.92% | ||
| 1 week | +38.24% | ||
| Current month | +30.24% | ||
| 1 month | +34.67% | ||
| 3 months | +29.98% | ||
| 6 months | -27.01% | ||
| Current year | -54.02% |
| 1 week | 4.78 |  | 6.66 |
| 1 month | 4.53 | | 7.52 |
| Current year | 1.55 | | 14.65 |
| 1 year | 1.55 | | 15.74 |
| 3 years | 1.55 | | 30.84 |
| 5 years | 1.55 | | 106.68 |
| 10 years | 1.55 | | 1,308 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Richman
CEO | Chief Executive Officer | 65 | 01/12/2015 |
Steven Cobourn
DFI | Director of Finance/CFO | 63 | 01/01/2018 |
Udayan Guha
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Richman
BRD | Director/Board Member | 65 | 01/12/2015 |
Elaine Jones
BRD | Director/Board Member | 71 | 01/12/2015 |
David Kabakoff
CHM | Chairman | 78 | 01/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/08/26 | Sell | Company | -30,000 | 0.6554% | ||
| 31/07/26 | Adar1 Capital Management LLC
| Buy | Company | 36,303 | 0.7931% | |
| 29/07/26 | Adar1 Capital Management LLC
| Buy | Company | 3,410 | 0.0944% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.92% | +38.24% | -45.49% | -48.94% | 2.9Cr | |
| +0.34% | +1.12% | +34.75% | +61.06% | 6.41TCr | |
| +0.98% | +2.68% | +12.25% | +82.98% | 5.55TCr | |
| +1.75% | +2.01% | +13.30% | +103.69% | 5.3TCr | |
| -1.43% | -1.17% | +26.27% | +52.86% | 4.6TCr | |
| -0.48% | -2.80% | +18.01% | +117.99% | 4.25TCr | |
| +0.82% | +1.37% | +227.94% | +922.41% | 4.04TCr | |
| -2.07% | +42.73% | +103.77% | +88.74% | 3.45TCr | |
| -0.26% | -2.57% | +12.55% | +45.18% | 3.23TCr | |
| +0.49% | -1.14% | +23.78% | -10.34% | 2.42TCr | |
| Average | +0.31% | +7.68% | +42.71% | +141.56% | 3.93TCr | |
| Weighted average by Cap. | +0.12% | +3.59% | +49.33% | +160.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.38Cr -3.03Cr -2.79Cr -2.53Cr -4.73Cr -321.87Cr -4.8Cr -33Cr -13Cr -168.45Cr -13Cr -12Cr -533.53Cr | -4.36Cr -3.91Cr -3.61Cr -3.26Cr -6.1Cr -415.67Cr -6.2Cr -43Cr -17Cr -217.54Cr -16Cr -16Cr -689.01Cr |
| Net Debt | - | - |
Employees
40
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | $6.525 | +2.92% | 58,258 |
| 28/26/28 | $6.340 | +10.94% | 64,544 |
| 27/26/27 | $5.715 | +9.38% | 1,42,088 |
| 26/26/26 | $5.225 | +4.92% | 25,400 |
| 23/26/23 | $4.980 | +5.51% | 48,546 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.525USD
Average target price
20.00USD
Spread / Average Target
+206.51%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NXTC Stock
Select your edition
All financial news and data tailored to specific country editions
